Home/Filings/4/0001899287-25-000003
4//SEC Filing

Bornstein Jonathan 4

Accession 0001899287-25-000003

CIK 0001899287other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 5:14 PM ET

Size

7.0 KB

Accession

0001899287-25-000003

Insider Transaction Report

Form 4
Period: 2025-03-10
Bornstein Jonathan
President of Amprius Lab
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-03-103,4710 total
    Exercise: $0.98From: 2016-01-01Exp: 2025-03-17Common stock (3,471 underlying)
  • Exercise/Conversion

    Common stock

    2025-03-10$0.98/sh+3,471$3,402422,668 total
Footnotes (1)
  • [F1]Includes 419,197 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Issuer

Amprius Technologies, Inc.

CIK 0001899287

Entity typeother

Related Parties

1
  • filerCIK 0001942459

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:14 PM ET
Size
7.0 KB